Wednesday, February 10, 2010, 4:38am EST - Canadian Markets open in 4 hours and 52 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

JIANGBO PHARMACEUTCL (JGBO.OB)

On Feb 9: 11.1499 USD   0.00 (0.00%)  
MORE ON JGBO.OB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
JIANGBO PHARMACEUTCL (OTC BB:JGBO.OB) Delayed quote dataEdit
Last Trade: 11.1499 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 11.1499
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 14.00
Day's Range: N/A - N/A
52wk Range: 3.31 - 21.00
Volume: 0
Avg Vol (3m): 4,955.56
Market Cap: N/A
P/E (ttm): N/A
EPS (ttm): N/A
Div & Yield: N/A (N/A%)
JIANGBO PHARMACEUTCL (JGBO.OB)
1d  5d  3m  6m  1y  2y  5y  max 
 Add JGBO.OB to Portfolio   Download Data

HEADLINES
China Biotech Week in Review: China Life Science Convergence
at Seeking Alpha (Mon, Jan 18)
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
PRNewswire (Wed, Jan 13)
Jiangbo Pharma Appears Significantly Undervalued
at Seeking Alpha (Tue, Jan 12)
Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
PRNewswire (Tue, Jan 12)
JIANGBO PHARMACEUTICALS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements
EDGAR Online (Thu, Jan 7)
China Sky One Medical, Inc. - Executive Interview, Yan-Qing Liu and Stanley Hao
Wall Street Transcript (Wed, Dec 9)
JIANGBO PHARMACEUTICALS, INC. Financials
EDGAR Online Financials (Fri, Nov 20)
JIANGBO PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online (Fri, Nov 20)
Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
PRNewswire (Tue, Nov 17)
JIANGBO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 16)
Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
PRNewswire (Mon, Nov 16)
Jiangbo Pharmaceuticals to Present at Brean Murray, Carret 2009 China Growth Conference
PRNewswire (Thu, Nov 12)
More Headlines for JGBO.OB...

ANALYST
EPS Est (next year) (Jun-10) : 2.25
EPS Est (in 2 years) (Jun-11) : 2.00
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
No business summary available for JGBO.OB.


Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices